Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.78 USD | +1.70% | -7.18% | -62.88% |
07/05 | Transcript : Moleculin Biotech, Inc. - Special Call | |
07/05 | Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.88% | 10.65M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.18% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- MBRX Stock
- News Moleculin Biotech, Inc.
- Maxim Adjusts Price Target on Moleculin Biotech to $20 From $45, Maintains Buy Rating